NCT01941251View on ClinicalTrials.gov

Navigated αTMS in Treatment-resistant Schizophrenia

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

December 31, 2025

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DEVICE

navigated Transcranial Magnetic Stimulation

"* individualized α frequency~* left DLPFC 110% motor threshold (MT)~* 13-15 sessions for 3 weeks"

DEVICE

navigated Transcranial Magnetic Stimulation

\- placebo treatment: sham coil

Trial Locations (1)

Unknown

Niuvanniemi Hospital, Kuopio

All Listed Sponsors
lead

Niuvanniemi Hospital

OTHER

NCT01941251 - Navigated αTMS in Treatment-resistant Schizophrenia | Biotech Hunter | Biotech Hunter